Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, October 23, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Affinia Therapeutics Raises $40 Million Series C to Advance Next-Generation Gene Therapies for Cardiovascular and Neurological Diseases
Life Sciences Times
-
October 7, 2025
0
People on the Move
Vensana Capital Launches Vensana Innovation, Appoints Thomas Tu, M.D., as Venture Partner and CEO
Life Sciences Times
-
October 7, 2025
0
Technology
Oath Surgical Raises $24 Million to Build First Surgeon-Owned, AI-Powered Surgical System
Life Sciences Times
-
October 6, 2025
0
Venture Capital
GordonMD Global Investments® Joins $125 Million Series D Financing for Star Therapeutics
Life Sciences Times
-
October 6, 2025
0
Venture Capital
Heidi Raises $65 Million in Series B Funding to Advance AI Care Partner for Clinicians
Life Sciences Times
-
October 6, 2025
0
Venture Capital
QuantHealth Secures Strategic Investment from Sanofi Ventures to Advance AI-Driven Clinical Trials
Life Sciences Times
-
October 1, 2025
0
People on the Move
Predicta Biosciences Raises $23.4 Million Series A to Advance Diagnostics for Blood Cancers and Autoimmune Diseases; Appoints Brian McKernan as CEO
Life Sciences Times
-
October 1, 2025
0
Venture Capital
Wysa Acquires Kins Physical Therapy to Bridge Gaps in U.S. Healthcare
Life Sciences Times
-
September 30, 2025
0
Venture Capital
Aarvik Therapeutics Closes Series Seed 2 Financing to Advance Next-Generation ADC Platform
Life Sciences Times
-
September 29, 2025
0
Venture Capital
Vyome Holdings Acquires MIT AI Spinout Oculo Health, Launches AI Psychiatry Unit
Life Sciences Times
-
September 29, 2025
0
Venture Capital
MEDiC Life Sciences Acquires Clinical-Stage Oncology Program, Leveraging Biomarker Platform for Precision Medicine
Life Sciences Times
-
September 24, 2025
0
People on the Move
Saisei Ventures Names James Feliciano as Venture Partner
Life Sciences Times
-
September 15, 2025
0
1
...
9
10
11
...
115
Page 10 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026